Evidence map›Paper›PMID 34945266›Full record

ReviewJournal of clinical medicine2021

Extracorporeal Shock Wave Therapy Combined with Complex Decongestive Therapy in Patients with Breast Cancer-Related Lymphedema: A Systemic Review and Meta-Analysis.

Yu Lin Tsai, Ting Jie I, Ya Chi Chuang, Yuan Yang Cheng, Yu Chun Lee

2 registry-linked trialsOpen access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 9 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 2 pooled it
0.7field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT06454734 narecruitingnot on this mapstarted 2024, after this paper: background citation

Lower Limb Lymphedema Treatment by Extracorporeal Shock Wave Therapy: Clinical Trial

TypeinterventionalSponsorParc de Salut MarRan2024 to 2026Enrolled30ConditionsLymphedema, Lower LimbArmsExtracorporeal shock wave therapy by radial device, Placebo extracorporeal shock wave therapy by radial device, DLT
NCT07626645 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Efficacy of Extracorporeal Shock Wave Therapy (ESWT) in Lower Extremity Lymphedema: A Randomized Controlled Trial

TypeinterventionalSponsorGazi UniversityRan2026 to 2027Enrolled36ConditionsLymphedema, Lower Limb, Extracorporeal Shock Wave Therapy, Edema Leg, Sham-controlledArmsExtracorporeal Shock Wave Therapy (ESWT), Sham Extracorporeal Shock Wave Therapy (Sham ESWT)
3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 2 syntheses or guidelines pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yu Lin TsaiDepartment of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan.ORCID 0000-0002-5267-6681
Ting Jie IDepartment of Medical Education, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Ya Chi ChuangDepartment of Medical Education, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Yuan Yang ChengDepartment of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Yu Chun LeeDepartment of Physical Medicine and Rehabilitation, Taichung Veterans General Hospital, Taichung 40705, Taiwan.
Taichung Veterans General Hospital · TWNational Yang Ming Chiao Tung University · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Breast cancer-related lymphedema (BCRL) is one of the most significant complications seen after surgery. Several studies demonstrated that extracorporeal shock wave therapy (ESWT), in addition to conventional complex decongestive therapy (CDT), had a positive effect on BCRL in various aspects. The systematic review and meta-analysis aim to explore the effectiveness of ESWT with or without CDT on BRCL patients. We searched PubMed, Embase, PEDro, Cochrane Library Databases, and Google Scholar for eligible articles and used PRISMA2020 for paper selection. Included studies were assessed by the PEDro score, Modified Jadad scale, STROBE assessment, and GRADE framework for the risk of bias evaluation. The primary outcomes were the volume of lymphedema and arm circumference. Secondary outcome measures were skin thickness, shoulder joint range of motion (ROM), and an impact on quality-of-life questionnaire. Studies were meta-analyzed with the mean difference (MD). Eight studies were included in the systemic review and four in the meta-analysis. In summary, we found that adjunctive ESWT may significantly improve the volume of lymphedema (MD = -76.44; 95% CI: -93.21, -59.68;

Indexed as

BCRLbreast cancerESWTextracorporeal shock wave therapylymphedemasystemic review and meta-analysis

Identifiers

PMID34945266
PMCPMC8705697
OpenAlexW4200360276

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.